AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Ursapharm Arzneimittel Tech Stack and Enterprise Applications

Ursapharm Arzneimittel Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2020 2020
Ursapharm Arzneimittel IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2019 2019
Application Hosting and Computing Services IaaS 2021 2021

IT Decision Makers and Key Stakeholders at Ursapharm Arzneimittel

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Ursapharm Arzneimittel Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Ursapharm Arzneimittel IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Ursapharm Arzneimittel digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Ursapharm Arzneimittel Technographics
Ursapharm Arzneimittel is a Life Sciences organization based in Germany, with around 73 employees and annual revenues of $233.0 million.
Ursapharm Arzneimittel operates a diverse technology stack with applications such as Microsoft 365 and Microsoft Azure Cloud Services, covering areas like Collaboration and Application Hosting and Computing Services.
Ursapharm Arzneimittel has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft.
Ursapharm Arzneimittel recently adopted applications including Hetzner in 2021, Microsoft 365 in 2020 and Microsoft Azure Cloud Services in 2019, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Ursapharm Arzneimittel’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Ursapharm Arzneimittel’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Ursapharm Arzneimittel technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.